Mechanistic insights and clinical relevance of the interaction between acute coronary syndromes and lipid metabolism

Seminars in Vascular Medicine

Volumn 4, Issue 2, 2004, Pages 197-202

  Correia, Luis C L ^a   Twickler, Marcel Th B ^b   Sposito, Andrei C ^a  

^a FUNDAÇÃO ZERBINI   (Brazil)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Acute coronary syndromes; Cholesterol; Lipoproteins; Triglycerides

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BIOSYNTHESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL TRIAL; CYTOKINE RELEASE; ENZYME ACTIVITY; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HORMONE SYNTHESIS; HUMAN; LIPID METABOLISM; LIVER CELL; MORTALITY; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; TISSUE REPAIR; UPREGULATION;

C-REACTIVE PROTEIN; CHOLESTEROL, LDL; HUMANS; LIPIDS; MYOCARDIAL INFARCTION; SYNDROME; TRIGLYCERIDES; TROPONIN I;

EID: 7244257501     PISSN: 15289648     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-835378     Document Type: Review

References (34)

1. Murray CJL, Lopes AD. Global comparative assessments in the health sector. World Health Organization; Geneva, Switzerland: 1994
2. Gotto AM Jr. Triglyceride: the forgotten risk factor. Circulation 1998;97(11):1027-1028
3. Ahnve S, Angelin B, Edhag O, Berglund L. Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention. J Intern Med 1989;226(5):297-301
4. Brugada R, Wenger NK, Jacobson TA, Clark WS, Cotsonis G, Iglesias A. Changes in plasma cholesterol levels after hospitalization for acute coronary events. Cardiology 1996;87(3):194-199
5. Fyfe T, Baxter RH, Cochran KM, Booth EM. Plasma-lipid changes after myocardial infarction. Lancet 1971;2(7732):997-1001
6. Wattanasuwan N, Khan IA, Gowda RM, Vasavada BC, Sacchi TJ. Effect of acute myocardial infarction on cholesterol ratios. Chest 2001;120(4):1196-1199
7. Rosenson RS. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 1993;22(3):933-940
8. Pfohl M, Schreiber I, Liebich HM, Haring HU, Hoffmeister HM. Upregulation of cholesterol synthesis after acute myocardial infarction-is cholesterol a positive acute phase reactant? Atherosclerosis 1999;142(2):389-393
9. Gore JM, Goldberg RJ, Matsumoto AS, Castelli WP, McNamara PM, Dalen JE. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol 1984;54(7):722-725
10. Ballantyne FC, Melville DA, McKenna JP, Morrison BA, Ballantyne D. Response of plasma lipoproteins and acute phase proteins to myocardial infarction. Clin Chim Acta 1979;99(1):85-92
11. Ritland S, Enger SC. Changes in the lipoprotein pattern during two years following myocardial infarction. Acta Med Scand 1972;191(5):447-450
12. Birchwood B. Serum lipids and lipoprotein following acute myocardial infarction in women. Nutr Metab 1972;14(1):38-47
13. Ryder RE, Hayes TM, Mulligan IP, Kingswood JC, Williams S, Owens DR. How soon after myocardial infarction should plasma lipid values be assessed? Br Med J (Clin Res Ed) 1984;289(6459):1651-1653
14. Kawano M, Namai K, Yaginuma T, Kawakami M, Kanazawa Y. Earlier decrease in plasma lipids than increase in C-reactive protein during very acute phase of myocardial infarction. Atherosclerosis 2001;156(2):477-478
15. Chatelain P, Latour JG, Tran D, de Lorgeril M, Dupras G, Bourassa M. Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation 1987;75(5):1083-1090
16. Bell D, Jackson M, Millar AM, Nicoll JJ, Connell M, Muir AL. The acute inflammatory response to myocardial infarction: imaging with indium-111 labelled autologous neutrophils. Br Heart J 1987;57(1):23-27
17. Ettinger WH, Varma VK, Sorci-Thomas M, et al. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. Arterioscler Thromb 1994;14(1):8-13
18. Sammalkorpi KT, Valtonen W, Maury CP. Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins. Ann Med 1990;22(6):397-401
19. de Beer FC, Soutar AK, Baltz ML, Trayner IM, Feinstein A, Pepys MB. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med 1982;156(1):230-242
20. Slunga L, Johnson O, Dahlen GH, Eriksson S. Lipoprotein(a) and acute-phase proteins in acute myocardial infarction. Scand J Clin Lab Invest 1992;52(2):95-101
21. Fresco C, Maggioni AP, Signorini S, et al. Variations in lipoprotein levels after myocardial infarction and unstable angina: the LATIN trial. Ital Heart J 2002;3(10):587-592
22. Correia LC, Sposito AC, Passos LC, et al. Short-term effect of atorvastatin (80 mg) on plasma lipids of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. Am J Cardiol 2002;90(2):162-164
23. Correia LC, Magalhaes LP, Santana O, et al. Effect of atorvastatin (80 mg) on recurrent ischemia in unstable angina pectoris or non-ST-elevation acute myocardial infarction. Am J Cardiol 2003;91(11):1355-1357
24. Correia LC, Sposito AC, Lima JC, et al. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. Am J Cardiol 2003;92(3):298-301
25. Krauss RM, Grunfeld C, Doerrler WT, Feingold KR. Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition. Endocrinology 1990;127(3):1016-1021
26. Feingold KR, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 1987;80(1):184-190
27. Querfeld U, Ong JM, Prehn J, et al. Effects of cytokines on the production of lipoprotein lipase in cultured human macrophages. J Lipid Res 1990;31(8):1379-1386
28. Kern PA. Recombinant human tumor necrosis factor does not inhibit lipoprotein lipase in primary cultures of isolated human adipocytes. J Lipid Res 1988;29(7):909-914
29. Friedman G, Barak V, Chajek-Shaul T, et al. Recombinant human interleukin-1 suppresses lipoprotein lipase activity, but not expression of lipoprotein lipase mRNA in mesenchymal rat heart cell cultures. Biochim Biophys Acta 1991;1089(1):83-87
30. Gerritsen J, TenVoorde BJ, Dekker JM, et al. Measures of cardiovascular autonomic nervous function: agreement, reproducibility, and reference values in middle age and elderly subjects. Diabetologia 2003;46(3):330-338
31. Klingenspor M, Ebbinghaus C, Hulshorst G, et al. Multiple regulatory steps are involved in the control of lipoprotein lipase activity in brown adipose tissue. J Lipid Res 1996;37(8):1685-1695
32. Pecquery R, Leneveu MC, Giudicelli Y. In vivo desensitization of the beta, but not the alpha 2-adrenoreceptor-coupled-adenylate cyclase system in hamster white adipocytes after administration of epinephrine. Endocrinology 1984;114(5):1576-1583
33. Lefebvre P, Luyckx A, Bacq ZM. Effects of denervation on the metabolism and the response to glucagon of white adipose tissue of rats. Horm Metab Res 1973;5(4):245-250
34. Omland T, Aarsland T, Aakvaag A, Lie RT, Dickstein K. Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction. Am J Cardiol 1993;72(3):255-259